Asam 2,4,5-Trifluorophenylacetic CAS 209995-38-0 Purity ≥99,5% (GC) Sitagliptin Fosfat Monohydrate Panengah Gambar Unggul

2,4,5-Asam Trifluorophenylacetic CAS 209995-38-0 Purity ≥99,5% (GC) Sitagliptin Fosfat Monohydrate Panengah

Katerangan pondok:

Ngaran Kimia: 2,4,5-Asam Trifluorophenylacetic

CAS: 209995-38-0

Purity: ≥99.5% (GC)

Penampilan: Bodas mun Pareum-Bodas Bubuk

Panengah Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) pikeun pengobatan diabetes tipe 2

Kualitas luhur, Produksi komérsial

E-Mail: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Pasokan Sitagliptin Phosphate Monohydrate Related Intermediate:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Asam Trifluorophenylacetic CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Asam Butyric CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3

Sipat Kimia:

Ngaran Kimia	2,4,5-Asam Trifluorophenylacetic
Nomer CAS	209995-38-0
Nomer CAT	RF-PI1191
Status Saham	Dina Stok, Skala Produksi Nepi ka Ton
Formula Molekul	C8H5F3O2
Beurat Molekul	190.12
Titik Lebur	121,0 nepi ka 125,0 ℃
Kalarutan	Leyur dina Métanol
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Bodas ka Pareum-Bodas Bubuk
Purity / Métode Analisis	≥99,5% (GC)
Kelembapan (KF)	≤0,50%
Résidu on Ignition	≤0,50%
Total Kotoran	≤0,50%
Standar tés	Standar Perusahaan
Pamakéan	Panganteur Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Paket & Panyimpenan:

Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang.

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap.

Kaunggulan:

FAQ:

Aplikasi:

Asam 2,4,5-Trifluorophenylacetic (CAS: 209995-38-0) mangrupikeun perantara tina Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9).Sitagliptin Phosphate (STG) dianggo pikeun ngubaran DM tipe 2 sabab ningkatkeun kontrol glikemik ku cara ningkatkeun tingkat hormon incretin aktif, GLP-1 (péptida-1) sareng GIP (péptida insulinotropik anu gumantung kana glukosa).Aktivasina incretins ieu dina sél β-pankréas ngabalukarkeun ngaronjat tingkat siklik adénosin monofosfat (cAMP) jeung kalsium intrasélular, kalawan sékrési insulin gumantung glukosa saterusna (2).Ubar hipoglikemik ieu kagolong kana kelas anyar anu disebut inhibitor dipeptidyl peptidase IV.STG disatujuan ku FDA dina 2006.